Learn More
Renal artery occlusive disease, from either atherosclerosis or fibrous dysplasia, may cause hypertension or renal insufficiency. Hypertension results from increased activity of the renin-angiotensin-aldosterone system. There are several ways to evaluate this system as well as several pharmacologic agents that will intervene and modulate the hypertension(More)
OBJECTIVE Our aim was to describe our experience of the Multilayer Flow Modulator (MFM, Cardiatis, Isnes, Belgium) used in the treatment of type III renal artery aneurysms (RAA). METHODS This is a single-centre study. 3 patients (2 men and 1 woman; mean age 59 years; range 41-77 years) underwent treatment of a type III renal artery aneurysm using the MFM.(More)
  • 1